<?xml version="1.0" encoding="UTF-8"?>
<p>Clinical evidence. 
 <italic>Pelargonium sidoides</italic> preparations have been trialed clinically for cough. In a randomized, controlled trial, involving 124 adults presenting acute bronchitis, were treated with 30 drops of EPs 7630
 <sup>®</sup>, for seven days. The treated group showed a significant improvement regarding the Bronchitis Severity Score (BSS) compared with the placebo group (
 <xref rid="B92" ref-type="bibr">Chuchalin et al., 2005</xref>). In a Cochrane review, the efficacy of 
 <italic>P. sidoides</italic> preparations in acute respiratory infections in RCT was assessed and indicated that it might be useful in the alleviation of symptoms of acute rhinosinusitis and the common cold in adults. However, the authors also raised concerns regarding the studies’ quality (
 <xref rid="B474" ref-type="bibr">Timmer et al., 2013</xref>). Similarly, Schapowals’ meta-analyses of randomized, double-blind, placebo-controlled trials concluded that it is useful in the management of the common cold (
 <xref rid="B435" ref-type="bibr">Schapowal et al., 2019</xref>). Overall, the clinical evidence is High for bronchitis and the common cold.
</p>
